Molecular epidemiology of MRSA in 13 ICUs from eight European countries
Journal of Antimicrobial and Chemotherapy January 2016 V.71 N.1 P.45-52
J. Hetem, L. P. G. Derde, J. Empel, A. Mroczkowska, M. Orczykowska-Kotyna, A. Kozińska, W. Hryniewicz, H. Goossens, and M. J. M. Bonten on behalf of the MOSAR WP3 Study Group
1Department of Clinical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands
2Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
3Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
4Department of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium
5Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands
Rigorous screening of carriage of MRSA, rather than relying on clinical isolates, together with standardized methods and centralized genotyping allowed for a more comprehensive and complete estimation of the prevalence and epidemiology of the isolates in the ICUs involved in the study.
Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Biología Molecular, Epidemiología, Health Care-Associated Infections, Infecciones nosocomiales, Metodos diagnosticos, Resistencia bacteriana, Sepsis, Update.